20 reports of this reaction
10.9% of all AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% reports
#2 most reported adverse reaction
SUNBURN is the #2 most commonly reported adverse reaction for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, manufactured by Beiersdorf Inc. There are 20 FDA adverse event reports linking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% to SUNBURN. This represents approximately 10.9% of all 183 adverse event reports for this drug.
Patients taking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10% who experience sunburn should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SUNBURN is a frequently reported adverse event for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, accounting for a significant proportion of all reports.
In addition to sunburn, the following adverse reactions have been reported for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%:
The following drugs have also been linked to sunburn in FDA adverse event reports:
SUNBURN has been reported as an adverse event in 20 FDA reports for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%. This does not prove causation, but indicates an association observed in post-market surveillance data.
SUNBURN accounts for approximately 10.9% of all adverse event reports for AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, making it one of the most commonly reported side effect.
If you experience sunburn while taking AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.